查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571769

生物製药製造消耗品测试的市场规模、份额和趋势分析报告：按服务、按原材料、按地区和细分趋势：2024-2030

Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share & Trends Analysis Report By Service (Laboratory, Custom), By Raw Material (Formulation Excipients, API), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

生物製药製造消耗品测试市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球生物製药製造耗材检测市场规模将达到12.7亿美元，2024年至2030年复合年增长率为12.3%。

推动这一市场发展的是对原材料深入评估的需求日益增长，以成功地将最终产品快速推向市场。对生物製药行业内部标准和外部法规的认识不断提高也推动了市场的成长。

近年来，发生了从小化学分子到生物大分子的重大模式转移。因此，生物製药行业正在朝着探索製造过程的各个方面的方向发展。

对最高品质原料和中间体的法规和品质期望不断提高。这迫使赋形剂和原料製造商投资于标准化功能和复杂的工艺，以一致地满足最终产品开发商的需求。

生物製药製造消耗品测试市场报告亮点

  • 从服务来看，由于各个製造商对符合监管标准的原材料的需求，药典测试和多药典测试占据了最大份额。
  • 由于该领域存在广泛的服务，原料药（API）测试服务占据了最大的销售份额。
  • 2023年全球市场将由北美主导，因为美国有大量的生技药品製造公司。市场参与企业之间的竞争加剧也是该地区占据较大份额的因素。
  • 亚太地区预计将成为成长最快的区域市场，这主要是由于亚洲国家合约服务产业的扩张。部分原因是这些国家的营运成本较低。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章生物製药製造消耗品测试市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 生物製药製造耗材测试市场分析工具
    • 波特的分析
    • PESTEL分析

第四章生物製药製造耗材测试市场：依服务估算及趋势分析

  • 细分仪表板
  • 生物製药製造消耗品测试市场：2023 年和 2030 年按服务分类的变化分析
  • 临床检查
  • 客自订测试/客户自己的测试
  • 药典和多药典考试

第五章生物製药製造耗材测试市场：依原料估算及趋势分析

  • 细分仪表板
  • 生物製药製造耗材测试市场：2023年及2030年原料变化分析
  • 配方添加物
  • 活性药物成分 (API)
  • 支援基于官方方法（USP/EP/JP）的供应商认证计划

第六章生物製药製造耗材测试市场：按地区估算及趋势分析

  • 2023年及2030年生物製药製造消耗品测试市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Alcami Corporation
    • Merck KGaA
    • Eurofins Scientific
    • Agilent Technologies, Inc.
    • Charles River Laboratories.
    • Catalent, Inc
    • Element Materials Technology（Avomeen Analytical Services）
    • Pace Analytical Services, LLC
    • Nelson Laboratories, LLC（Gibraltar Laboratories）
简介目录
Product Code: GVR-2-68038-398-0

Biopharmaceuticals Manufacturing Consumables Testing Market Growth & Trends:

The global biopharmaceuticals manufacturing consumables testing market size is expected to reach USD 1.27 billion by 2030, registering a CAGR of 12.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth.

In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.

Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.

Biopharmaceuticals Manufacturing Consumables Testing Market Report Highlights:

  • Based on service, compendial and multi-compendial testing held the largest share owing to demand from various manufacturers for raw materials that are compliant to regulatory standards
  • Testing services for Active Pharmaceutical Ingredients (APIs) accounted for the largest revenue share owing to the presence of a wide range of services in this segment
  • Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2023. Rising competitive rivalry amongst market participants is also attributive for the large share of this region
  • Asia Pacific is expected to emerge as the fastest-growing regional market, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biopharmaceuticals Manufacturing Consumables Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Biopharmaceuticals Manufacturing Consumables Testing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Laboratory Testing
    • 4.3.1. Laboratory Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 4.4. Custom Testing / Customer Proprietary Testing
    • 4.4.1. Custom Testing / Customer Proprietary Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 4.5. Compendial & Multi Compendial Laboratory Testing
    • 4.5.1. Compendial & Multi Compendial Laboratory Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)

Chapter 5. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Formulation Excipients
    • 5.3.1. Formulation Excipients Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 5.4. Active Pharmaceutical Ingredients (API)
    • 5.4.1. Active Pharmaceutical Ingredients (API) Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 5.5. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support
    • 5.5.1. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)

Chapter 6. Biopharmaceuticals Manufacturing Consumables Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Biopharmaceuticals Manufacturing Consumables Testing Market Share, By Region, 2023 & 2030, USD Million
  • 6.2. North America
    • 6.2.1. North America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Alcami Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Eurofins Scientific
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Agilent Technologies, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Charles River Laboratories.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Catalent, Inc
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Element Materials Technology (Avomeen Analytical Services)
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Pace Analytical Services, LLC
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Nelson Laboratories, LLC (Gibraltar Laboratories)
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives